Clinical trial Recruiting at 1 site Interventional Ages 18 to 70

Evaluating electroacupuncture for bladder pain syndrome

Official title: Electroacupuncture for Bladder Pain Syndrome: An Randomized Controlled Trial and Study for Central Mechanism

Run by The Third Affiliated hospital of Zhejiang Chinese Medical University · NCT05279963 · Data updated 2026-11-12

This study is testing if electroacupuncture can help people with bladder pain syndrome feel better compared to medication and a fake treatment.

Quick facts

Study typeInterventional
Ages18 Years to 70 Years
SexAll
Enrollment84 (estimated)
SponsorThe Third Affiliated hospital of Zhejiang Chinese Medical University
Academic / other
Locations1 site (Hangzhou, Zhejiang)
StatusRecruiting
StartedMarch 16, 2022
Main results expectedDecember 24, 2024
Study endsJanuary 23, 2025
Registry record updatedDecember 3, 2024
Trial IDNCT05279963 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 to 70 who meet specific diagnostic criteria for bladder pain syndrome and have moderate to severe pain levels.

Probably not a fit

Patients with significant organic lesions or severe primary diseases, as well as those who cannot undergo electroacupuncture, may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This trial aims to assess the efficacy and safety of electroacupuncture in treating bladder pain syndrome (BPS) through a randomized controlled design. Participants will be randomly assigned to one of three groups: medication, electroacupuncture, or sham acupuncture, with a 1:2:1 allocation ratio. The study will involve a 4-week treatment phase followed by a 4-week follow-up, during which outcomes will be evaluated at multiple time points. The trial will utilize fMRI to analyze brain activity related to symptom relief, while ensuring blinding for outcome assessors and statisticians to minimize bias.

Why it matters

Potential benefit: If successful, this study could provide a non-pharmacological treatment option for patients suffering from bladder pain syndrome.

How similar studies have gone: While acupuncture has been studied for various conditions, this specific approach using electroacupuncture for bladder pain syndrome is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* 18 ≤ age ≤70 years, male or female;
* Must fulfill the first and the second diagnostic criteria;
* 30 mm≤ VAS score ≤80mm;
* Participants can fully understand the study protocol and a written informed consent is signed.

Exclusion Criteria:

* Patients with previous bladder stones or other space-occupying lesions;
* Previous positive urine culture or significant abnormal urine routine;
* Significant organic lesions of genitourinary system and pelvic organs;
* Patients suffer from severe primary diseases such as cardiovascular, cerebrovascular, respiratory, liver and kidney, or patients cannot receive EA treatment due to any reasons;
* People with heart stents and other metallic substances in their bodies;
* Women who are pregnant, planning to become pregnant, breast-feeding or allergic to study drugs;
* Patients have participated in other clinical trials within the last 3 months.

Where it's running

  • The Third Affiliated Hospital of Zhejiang Chinese Medical University
    Hangzhou, Zhejiang, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.